Instant 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot

Foot and Ankle International

Volumn 27, Issue 9, 2006, Pages 716-722

  Dutta, Pinaki ^a,b   Bhansali, Anil ^a,b   Mittal, Bhagwant R ^a,b   Singh, Baljnder ^a,b   Masoodi, Sariq R ^a,c  

^a PGIMER ^*

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c Endocrinology Postgraduate Institute of Medical and Educational Research   (India)

Author keywords

Bone Infections; Diabetes; Scintigraphy

Indexed keywords

ALBUMIN; CIPROFLOXACIN; CREATININE; MEDRONATE TECHNETIUM TC 99M; TECHNETIUM 99M;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BONE SCINTISCANNING; CLINICAL ARTICLE; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ESCHERICHIA COLI; FALSE POSITIVE RESULT; FOOT RADIOGRAPHY; FOOT ULCER; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOMYELITIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 33748546958     PISSN: 10711007     EISSN: None     Source Type: Journal    
DOI: 10.1177/107110070602700911     Document Type: Article

References (33)

1. 99m Ciprofloxacin (infection) for detecting sites of inflammation in arthritis. Rheumatology (Oxford) 42:1179-1182, 2003.
2. Bhansali, A; Chattopadhyay, A; Dash, RJ: Mortality in diabetes a retrospective analysis from a tertiary care hospital in north India. Diabetes Res. Clin. Pract. 60:119-124, 2003.
3. 99mTc-Dextran in tubercular bone disease. Ind. J. Nuclear Med. 14:10-16, 1999.
4. Britton, KE; Vinjamuri, S; Hall, AV; et al.: Clinical evaluation of technetium-99m infection for the localisation of bacterial infection. Eur. J. Nucl. Med. 5:553-556, 1997.
5. Burkhardt, JE; Walterspeil, JN; Schaad, UB: Quinolone arthropathy in animals versus children. Clin. Infect. Dis. 25:1196-1204, 1997.
6. Cavanagh, PR; Young, MJ; Adams, JE; Vickers, KL; Boulton, AJM: Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 17:201-209, 1994.
7. Caputo, GM; Cavanagh, PR; Ulbrecht, JS; Gibbons, GW; Karchmer, AW: Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med. 331:854-860, 1994.
8. Crerand, S; Dolan, M; Laing, P; et al.: Diagnosis of osteomyelitis in neuropathic foot ulcers. J. Bone Joint Surg. 78-B:51-55, 1996.
9. Drlica, K; Zhao, X: DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392, 1997.
10. Froelich, JW; Swanson, D: Imaging of inflammatory process with labeled cells. Semin. Nucl. Med. 14:128-140, 1984.
11. 99mT c-ciprofloxacin in clinically selected patients for peripheral osteomyelitis and fever of unknown origin. Nuklearmedizin 41:30-36, 2002.
12. Grayson, ML; Gibbons, GW; Balogh, K; Levin, E; Karchmer, AW: Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. J. Am. Med. Assoc. 273:721-723, 1995.
13. Gold, RH; Tong, DFJ; Crim, JR; Seeger, LL: Imaging the diabetic foot. Skeletal Radiol. 24:563-571, 1995.
14. 99m infection, a novel agent for detecting sites of infection. J. Clin. Pathol. 1:215-219, 1998.
15. Hooper, DC; Wolfson, JS: Fluoroquinolone anti microbial agents. N. Engl. J. Med. 324:384-394, 1991.
16. 67Gallium scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int. 17:10-16, 1996.
17. Lipsky, BA: Osteomyelitis of the foot in diabetic patients. Clin. Infect. Dis. 25:1318-1326, 1997.
18. 99mTc-ciprofloxacin radio-pharmaceutical for the detection of bone infection. Clin. Microbial Infect. 9:101-109, 2003.
19. Oethinger, M; Kern, WV; Jellen-Ritter, AS; McMurry, LM; Levy, SB: Ineffectiveness of topoisomerase, mutations in mediating clinically significant fluroquinolone resistance in Eescherichia Coli in the absence of the Acr Ab efflux pump. Antimicro. Agents Chemother. 44:10-13, 2000.
20. Pedowitz, WJ: Diagnosis and treatment of infections of the diabetic foot. Foot Ankle Clin. 2:89-98, 1997.
21. Peters, AM; Danpure, HJ; Osman, S; et al.: Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labeling leucocytes and imaging inflammation. Lancet 2:946-949, 1986.
22. Peters, AM: The use of nuclear medicine in infections. Br. J. Radiol. 71:252-261, 1998.
23. 99mTc-MDP bone scintigraphy. Diabetes Metabol. 28:485-490, 2002.
24. Ramachandran, A; Snehalatha, C; Latha, E; Vijay, V; Viswanathan, M: Rising prevalence of NIDDM in urban population in India. Diabetolagia 40:232-237, 1997.
25. Rubin, HB; Fischman, AJ: The use of radiolabeled non-specific immunoglobulin in the detection of focal inflammation. Semin. Nucl. Med. 24:169-179, 1994.
26. Schauwecker, DS: The scintigraphy diagnosis of osteomyelitis. Am. J. Roentgenol. 158:9-18, 1992.
27. Segarra, I; Roca, M; Baliellas, C; et al.: Granulocyte-specific monoclonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labeled leucocyte scintigraphy in inflammatory bowel disease. Eur. J. Nucl. Med. 18:715-719, 1991.
28. Singh, B; Mittal, BR; Bhattacharya A, et al.: 99mTc-ciprofloxacin imaging in the diagnosis of post-surgical bony infection and evaluation of response to antibiotic therapy - a case report. J. Orthopaed. Surg. 18:15, 2004.
29. Singh, AK; Verma, J; Sharma, RK; Bose, M; Bhatnagar, A: Development and indigenization and evaluation of a cold kit for instant preparation Tc-99m Ciprofloxacin. Ind. J. Nucl. Med. 14:109, 1999.
30. Solanki, KK; Bomanji, J; Siraj, Q; Small, M; Britton, KE: Tc-99m Infection-a new class of radiopharmaceutical for imaging infection. J. Nucl. Med. 34:119P, 1993.
31. 99mTc-ciplox scan in diagnosis of chronic orthopedic infections Comparative study with 99mTc-HMPAO leukocyte scintigraphy. J. Nucl. Med. 42:567-574, 2001.
32. Wang, A; Weinstein, D; Greenfield, L; et al.: MRI and diabetic foot infections. Magn. Reson. Imaging 8:805-809, 1990.
33. Zargar, AH; Wani, AI; Masoodi, SR; Laway, BA; Bashir, MI: Mortality in diabetes mellitus: data from a developing region of the world. Diabetes Res. Clin. Pract. 32:67-74, 1999.